Schedule 13G ownership disclosure
Celldex Therapeutics Inc
Security class unavailable · CUSIP: 15117B202
Event date: 2020-06-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-20-011453
- Form type
- SC 13G
- Filer
- Celldex Therapeutics, Inc.
- CIK
- CIK 744218
- Filed
- Jun 19, 2020
- Reporting period
- Jun 11, 2020
- Description
- Schedule 13G beneficial ownership